NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

meirluc,

I think that will be a final report. They may be waiting for more separation between early vs late treatment patients or something else but if NWBO does not report some good news this month or next they will be courting financial ruin. At a minimum they would need to give very good reasons, using solid data points, for any further delay in the Phase 3 L trial and get the sarcoma trial started with outside funding. I hope they share even more than this. Best wishes.